NCT06997900 - Menopur And Rekovelle Combination Study Version 2.0 | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

July 4, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions

IVFControlled Ovarian SimulationFertility Disorders

Interventions

DRUG

Combination therapy : Follitropin delta and HP-hMG

Follitropin delta dose will be determined by age. Highly purified human menopausal gonadotrophin will be determined by follitropin delta dose and body weight.

Trial Locations (2)

Unknown

RECRUITING

Ottawa fertility centre, Ottawa

H4P 2S4

RECRUITING

Clinique ovo, Montreal